(Q82286516)

English

Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation

scientific article published on 14 October 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

prostate cancer

1 reference

based on heuristic

inferred from title

Daniel A Galvão

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Dennis R. Taaffe

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

N Spry

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

D Joseph

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

D Turner

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

R U Newton

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

14 October 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Prostate Cancer and Prostatic Diseases

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

198-203

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

https://scigraph.springernature.com/pub.10.1038/pcan.2008.51

0 references

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

National practice patterns and time trends in androgen ablation for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Insulin sensitivity during combined androgen blockade for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Sarcopenia: origins and clinical relevance

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Perspectives on comorbidity and cancer in older patients: approaches to expand the knowledge base

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Once-weekly resistance exercise improves muscle strength and neuromuscular performance in older adults

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Resistance exercise dosage in older adults: single- versus multiset effects on physical performance and body composition

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

High-intensity strength training in nonagenarians. Effects on skeletal muscle

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Lower extremity physical performance and hip bone mineral density in elderly black and white men and women: cross-sectional associations in the Health ABC Study

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Estimating cardiorespiratory fitness in well-functioning older adults: treadmill validation of the long distance corridor walk

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Association of Long-Distance Corridor Walk Performance With Mortality, Cardiovascular Disease, Mobility Limitation, and Disability

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Measuring Fitness in Healthy Older Adults: The Health ABC Long Distance Corridor Walk

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Quantifying the effect of hand preference on upper limb bone mineral and soft tissue composition in young and elderly women by dual-energy X-ray absorptiometry.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Appendicular skeletal muscle mass: measurement by dual-photon absorptiometry

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Physical function in men with prostate cancer on androgen deprivation therapy

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Physical function changes in prostate cancer patients on androgen deprivation therapy: a 2-year prospective study

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Exercise capacity and mortality among men referred for exercise testing.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Long-term effects of androgen deprivation therapy in prostate cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Osteoporosis during androgen deprivation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Changes in bone mineral density and body composition during initial and long-term gonadotropin-releasing hormone agonist treatment for prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Quality of life, morbidity, and mortality after low trauma hip fracture in men.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Endocrine and immune responses to resistance training in prostate cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Resistance Training and Reduction of Treatment Side Effects in Prostate Cancer Patients

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2008.51

31 March 2020

Identifiers

10.1038/PCAN.2008.51

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18852703%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q82286516&oldid=2005448033"